首页 | 本学科首页   官方微博 | 高级检索  
     

受体型酪氨酸激酶RON在乳腺癌侵袭及转移中的作用研究进展
引用本文:莫光泉,张宏颖,李连宏. 受体型酪氨酸激酶RON在乳腺癌侵袭及转移中的作用研究进展[J]. 大连医科大学学报, 2011, 33(4): 391-396
作者姓名:莫光泉  张宏颖  李连宏
作者单位:大连医科大学病理学与法医学教研室,辽宁大连,116044
摘    要:受体型酪氨酸激酶RON是原癌基因c—MET家族的一员。本文在简介原癌基因RON的生物学特征的基础上,综述了RON在乳腺癌侵袭及转移中的作用的研究进展,包括RON在乳腺癌中的异常表达、RON变异体、RON促进细胞迁移、肿瘤细胞附着、肿瘤生长和血管生成作用以及其在溶骨性骨转移中的作用等。单克隆抗体、小分子抑制物和特异性siRNA等靶向RON的治疗方法在乳腺癌治疗中有一定的潜在价值。

关 键 词:孔腺肿瘤  受体型酪氨酸激酶RON  侵袭  转移  靶向治疗

Development in the role of receptor tyrosine kinase RON in invasion and metastasis of human breast cancer
MO Guang-quan,ZHANG Hong-ying and LI Lian-hong. Development in the role of receptor tyrosine kinase RON in invasion and metastasis of human breast cancer[J]. Journal of Dalian Medical University, 2011, 33(4): 391-396
Authors:MO Guang-quan  ZHANG Hong-ying  LI Lian-hong
Affiliation:(Department of Pathology & Forensic Medicine,Dalian Medical University,Dalian 116044,China)
Abstract:The receptor tyrosine kinase RON belongs to the c-MET proto-oncogene family.In this review the biological characteristics of RON were briefly introduced.In recent years,more and more research results indicate that RON may take an important role in invasion and metastasis of human breast cancer by aberrant expression in breast cancer,RON variants,promoting tumor cell migration,cell adhesion,invasive growth,angiogenesis as well as proteolytic bone metastasis.Targeted therapeutics using specific monoclonal antibodies,small-molecule inhibitors or siRNA have potential value in the treatment of breast cancer.
Keywords:breast neoplasms  receptor tyrosine kinase RON  neoplasm invasiveness  matastasis  targeted therapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《大连医科大学学报》浏览原始摘要信息
点击此处可从《大连医科大学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号